News

The Swedish Patent and Registration Office, PRV, has granted Iconovo’s first ICOone patent. This is a key milestone showing that Iconovo’s inhalers are novel and inventive. More patent applications regarding ICOres, ICOcap and ICOone will soon enter the PCT phase.